The Parenteral Drug Administration – An Evolving Spectrum
Parenteral drug administration has gone on to witness quite a significant set of advancements as well as transformations in recent years. This very crucial method when it comes to drug delivery happens to be playing a very pivotal role when it comes to delivering therapeutic agents directly in the bloodstream, hence offering rapid as well […]
Respiratory Syncytial Virus Jab From Moderna Gets FDA Nod
Moderna has gone on to announce in May 2023 that the US FDA has gone on to approve its respiratory syncytial virus- RSV vaccine, which is for adults aged 60 years and older. It is well to be noted that this is going to be the only RSV vaccine that is going to be available […]
Syntegon launches modular bioprocessing platform at Achema
Innovative modular concept shortens lead times and lowers costs Full functionality off-the-shelf for both clinical and commercial production Fully integrated and automated for maximum efficiency and quality assurance Waiblingen/Frankfurt (Germany), June 10, 2024. Achema 2024 has opened its doors – and visitors to the Syntegon booth are in for a surprise: the Syntegon subsidiary Pharmatec […]
ChargePoint Technology launches new robotic solution to help transform the future of GMP manufacturing
ChargePoint Technology, a powder and liquid transfer specialist, has announced the launch of a new robotic material handling solution aimed at increasing safety and efficiency in solid dosage drug manufacturing. The new robotics solution will improve efficiency for manufacturers looking to automate and update their production processes to meet future demand for delivering life-saving drug […]
By 2033, World Market For APIs Could Reach US$ 384 Billion
The worldwide active pharmaceutical ingredient market size happened to be valued at $214.72 billion in 2023 and is all set to reach a $384 billion valuation by 2033 with a CAR of 6.08% right from 2024 to 2033. Integration when it comes to the APIs goes on to play a very important role as a […]
Meaningful Investment To Enable Tirzepatide API Production
It is well to be noted that a fresh $5.3 billion investment for pharma giant Eli Lilly and Company’s manufacturing site based in Lebanon, Indiana, US has gone on to raise the organization’s total investment in the country from $3 billion to $9 billion. The fact is that this sort of expansion is going to […]
Market Forecast For Innovative Small Molecule Injectables
A Business Research Company report goes on to predict that the small-molecule injectable drug market is going to be valued at approximately $355 billion in 2028. The CAGR is anticipated to be almost 13% up to the said year. Elements that are expected to help in this growth within the market go on to include […]
Germany – Taking Right Steps Towards Pharma Drugs Reshoring
As part of its endeavors to throttle the pharma sector domestically, the German government has gone ahead with the adoption of a strategy paper in December 2023, which identified three major areas that need to be strengthened. The objectives include unbureaucratic nods when it comes to clinical trials along with the medicinal products. Second, seamless […]
Global Biopharmaceutical Market To Reach New Heights By 2032
The worldwide biopharmaceutical market is all set to have prominent growth, with the value anticipated to reach $566 billion by 2032, which is up from $263 billion in 2022, thereby reflecting a CAGR of almost 8% from 2023 to 2032. This progress, primarily happens to be driven by the growing prevalence when it comes to […]
Generative AI In The Biopharmaceutical Manufacturing Sphere
As per a new Axendia Market Research Report: The State of Generative AI in Life Sciences: The Good, the Bad, and the Ugly, among the pharmaceutical DX-digital transformation pros, 67% went on to answer- not ready when asked about how ready the life sciences sector is to effectively go ahead and leverage generative AI when […]
